Literature DB >> 19715424

Image-guided convection-enhanced delivery of muscimol to the primate brain.

John D Heiss1, Stuart Walbridge, Ashok R Asthagiri, Russell R Lonser.   

Abstract

OBJECT: Muscimol is a potent gamma-aminobutyric acid-A receptor agonist that temporarily and selectively suppresses neurons. Targeted muscimol suppression of neuronal structures could provide insight into the pathophysiological processes and treatment of a variety of neurological disorders. To determine if muscimol delivered to the brain by convection-enhanced delivery could be monitored using a coinfused surrogate MR imaging tracer, the authors perfused the striata of primates with tritiated muscimol and Gd-diethylenetriamine pentaacetic acid (DTPA).
METHODS: Three primates underwent convective coinfusion of (3)H-muscimol (0.8 microM) and Gd-DTPA (5 mM) into the bilateral striata. Primates underwent serial MR imaging during infusion, and the animals were killed immediately after infusion. Postmortem quantitative autoradiography and histological analysis was performed.
RESULTS: Real-time MR imaging revealed that infusate (tritiated muscimol and Gd-DTPA) distribution was clearly discernible from the noninfused parenchyma. Real-time MR imaging of the infusion revealed the precise region of anatomical perfusion in each animal. Imaging analysis during infusion revealed that the distribution volume (Vd) of infusate linearly increased (R = 0.92) with volume of infusion (Vi). Overall, the mean (+/- SD) Vd/Vi ratio was 8.2 +/- 1.3. Autoradiographic analysis revealed that MR imaging of Gd-DTPA closely correlated with the distribution of (3)H-muscimol, and precisely estimated its Vd (mean difference in Vd, 7.4%). Quantitative autoradiograms revealed that muscimol was homogeneously distributed over the perfused region in a square-shaped concentration profile.
CONCLUSIONS: Muscimol can be effectively delivered to clinically relevant volumes of the primate brain. Moreover, the distribution of muscimol can be tracked using coinfusion of Gd-DTPA and MR imaging. The ability to perform accurate monitoring and to control the anatomical extent of muscimol distribution during its convection-enhanced delivery will enhance safety, permit correlations of muscimol distribution with clinical effect, and should lead to an improved understanding of the pathophysiological processes underlying a variety of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19715424      PMCID: PMC2853729          DOI: 10.3171/2009.7.JNS09652

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

1.  Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion.

Authors:  Russell R Lonser; Stuart Walbridge; Kayhan Garmestani; John A Butman; Hugh A Walters; Alexander O Vortmeyer; Paul F Morrison; Martin W Brechbiel; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

2.  Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging.

Authors:  Tung T Nguyen; Yashdip S Pannu; Cynthia Sung; Robert L Dedrick; Stuart Walbridge; Martin W Brechbiel; Kayhan Garmestani; Markus Beitzel; Alexander T Yordanov; Edward H Oldfield
Journal:  J Neurosurg       Date:  2003-03       Impact factor: 5.115

Review 3.  New methods of drug delivery.

Authors:  R Langer
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

4.  Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging.

Authors:  D W Laske; P F Morrison; D M Lieberman; M E Corthesy; J C Reynolds; P A Stewart-Henney; S S Koong; A Cummins; C H Paik; E H Oldfield
Journal:  J Neurosurg       Date:  1997-10       Impact factor: 5.115

Review 5.  Drug delivery to the brain.

Authors:  W M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  1997-07       Impact factor: 6.200

6.  Distribution and metabolism of muscimol in the brain and other tissues of the rat.

Authors:  M Baraldi; L Grandison; A Guidotti
Journal:  Neuropharmacology       Date:  1979-01       Impact factor: 5.250

7.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms.

Authors:  R Levy; A E Lang; J O Dostrovsky; P Pahapill; J Romas; J Saint-Cyr; W D Hutchison; A M Lozano
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

9.  Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging.

Authors:  F M Cavagna; F Maggioni; P M Castelli; M Daprà; L G Imperatori; V Lorusso; B G Jenkins
Journal:  Invest Radiol       Date:  1997-12       Impact factor: 6.016

10.  Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.

Authors:  D M Lieberman; D W Laske; P F Morrison; K S Bankiewicz; E H Oldfield
Journal:  J Neurosurg       Date:  1995-06       Impact factor: 5.115

View more
  30 in total

1.  Neurological surgery at the National Institutes of Health.

Authors:  Gautam U Mehta; John D Heiss; John K Park; Ashok R Asthagiri; Kareem A Zaghloul; Russell R Lonser
Journal:  World Neurosurg       Date:  2010-07       Impact factor: 2.104

Review 2.  Oligonucleotide therapeutic approaches for Huntington disease.

Authors:  Dinah W Y Sah; Neil Aronin
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Functional imaging reveals rapid reorganization of cortical activity after parietal inactivation in monkeys.

Authors:  Melanie Wilke; Igor Kagan; Richard A Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-04       Impact factor: 11.205

4.  Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain.

Authors:  R Mark Richardson; Adrian P Kells; Alastair J Martin; Paul S Larson; Philip A Starr; Peter G Piferi; Geoffrey Bates; Lisa Tansey; Kathryn H Rosenbluth; John R Bringas; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Stereotact Funct Neurosurg       Date:  2011-04-14       Impact factor: 1.875

5.  Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer.

Authors:  Ashok R Asthagiri; Stuart Walbridge; John D Heiss; Russell R Lonser
Journal:  J Neurosurg       Date:  2011-05-27       Impact factor: 5.115

6.  Focal, remote-controlled, chronic chemical modulation of brain microstructures.

Authors:  Khalil B Ramadi; Canan Dagdeviren; Kevin C Spencer; Pauline Joe; Max Cotler; Erin Rousseau; Carlos Nunez-Lopez; Ann M Graybiel; Robert Langer; Michael J Cima
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

Review 7.  Imaging of Convective Drug Delivery in the Nervous System.

Authors:  Russell R Lonser
Journal:  Neurosurg Clin N Am       Date:  2017-08-19       Impact factor: 2.509

8.  Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas.

Authors:  Prashant Chittiboina; John D Heiss; Katherine E Warren; Russell R Lonser
Journal:  J Neurosurg Pediatr       Date:  2014-01-10       Impact factor: 2.375

9.  Comparison of pulsed versus continuous convective flow for central nervous system tissue perfusion: laboratory investigation.

Authors:  Edjah K Nduom; Stuart Walbridge; Russell R Lonser
Journal:  J Neurosurg       Date:  2012-10-12       Impact factor: 5.115

10.  Inactivation of the parietal reach region causes optic ataxia, impairing reaches but not saccades.

Authors:  Eun Jung Hwang; Markus Hauschild; Melanie Wilke; Richard A Andersen
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.